- 专利标题： BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS
-
申请号： EP20201593.9申请日： 2014-05-16
-
公开(公告)号： EP3786162A1公开(公告)日： 2021-03-03
- 发明人: LI, Yun-Long , ZHUO, Jincong , QIAN, Ding-Quan , MEI, Song , CAO, Ganfeng , PAN, Yongchun , LI, Qun , JIA, Zhongjiang
- 申请人： Incyte Corporation
- 申请人地址： US Wilmington, DE 19803 1801 Augustine Cut-Off
- 代理机构： Warner, James Alexander
- 优先权： US201361824683 P 20130517
- 主分类号： C07D403/14
- IPC分类号： C07D403/14 ; A61K31/4155 ; A61P37/00 ; A61P35/00 ; A61P29/00
摘要：
The present invention provides compounds of Formula I:
or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
公开/授权文献
- EP3786162B1 BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS 公开/授权日：2023-08-09
信息查询
